Back
DELHI HIGH COURT
PRATHIBA M.SINGH
Dharmendra Kumar Aggarwal – Appellant
Versus
Govt. of NCT of Delhi – Respondent
| Table of Content |
|---|
| 1. urgent supply of tocilizumab for covid-19 patient (Para 2 , 4) |
| 2. court assurance for drug distribution efforts (Para 3 , 8 , 9) |
| 3. consideration for additional patient requiring tocilizumab (Para 5 , 6) |
| 4. clarification on tocilizumab stock status (Para 10 , 11 , 12) |
| 5. discussion on manufacturing and import issues (Para 13 , 14) |
| 6. court observations on patent rights and responsibilities (Para 15 , 16 , 17) |
| 7. foundational court directions for addressing drug distribution (Para 18) |
| 8. conclusion and scheduling of subsequent hearings (Para 19 , 20 , 21) |
JUDGMENT
Prathiba M. Singh, J. (Oral)--This hearing has been done through video conferencing.
2. The present petition has been filed by the brother of Shri Sudhir Kumar Agarwal, who is a COVID-19 patient (hereinafter, "patient"), and is currently admitted in Malik Radix Health Care Hospital, Nirman Vihar, New Delhi. The prayer in the petition is to issue directions to the Respondents in the petition, to urgently supply the Tocilizumab injection - Actemra 400 mg to the said hospital, so that the same can be administered to the patient urgently.
3. The matter was taken up, on an urgent basis, yesterday, and this cour
Court emphasizes urgency and coordinated efforts to ensure availability of critical medicine for COVID-19 patients while addressing broader supply chain issues.
Urgent assessment and supply of essential drugs in public health emergencies.
The main legal point established is the court's intervention to address the shortage of Tocilizumab 400 MG for COVID-19 patients in India, emphasizing the need for the manufacturer to meet the demand....
The court asserted the need for government accountability in drug distribution and ordered comprehensive reporting on the supply capabilities of Tocilizumab amid urgent demand due to COVID-19.
The central legal point established in the judgment is the uncertainty in the further imports of Tocilizumab to India and the efforts made by Roche India to import and supply the drug, as well as the....
During a national emergency, the government can exercise powers under the Patents Act to ensure the availability of essential drugs, emphasizing public health needs amid a pandemic.
The main legal point established is the need for immediate availability of essential drugs, such as Tocilizumab, for critically ill COVID-19 patients and the provisions of the Patents Act allowing fo....
The court mandated that the immediate availability of essential drugs like Remdesivir must be ensured during public health emergencies, stressing the need for systemic improvements in drug allocation....
COVID-19 pandemic - frustration and harassment due to non-availability of Remdesivir, which is a prescribed drug for COVID-19 patients - Nodal Officer of GNCTD, who is dealing with Remdesivir, as als....
Interim order modified - It is settled law Court always has power to vary or modify any interim order for good and cogent reason. Respondent-Applicant had made a voluntary statement that in meantime;....
An indispensable Tool for Legal Professionals, Endorsed by Various High Court and Judicial Officers
Please visit our Training & Support
Center or Contact Us for assistance
Scan Me!
India’s Legal research and Law Firm App, Download now!
For Daily Legal Updates, Join us on :
Back to top
